Recent studies have identified that MALAT1 can effectively regulate proliferation and inflammatory responses in ischemia/reperfusion-induced AKI, while TapSAKI and RP11-354P17.15-001 can sensitively predict the occurrence of AKI in renal allograft recipients 17-19. Here, MALAT1 is linked to acute kidney injury.